Nuvation Bio Funding: $275M Raised, Series A (2019)
Nuvation Bio is based in New York, NY. It has raised $275M in total funding. Latest round: Series A.
Nuvation Bio funding overview
Nuvation Bio is based in New York, NY. Nuvation Bio has raised $275M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in October 2019. The round record for Nuvation Bio runs through 2019; nothing later has been disclosed. Investors on record include Omega Funds, Aisling Capital, Altitude Life Science Ventures, The Baupost Group, Boxer Capital of the Tavistock Group, EDBI and 6 others. 12 distinct backers are named across the disclosed rounds.
Nuvation Bio at a glance
Total raised
$275M
Latest round
Series A
Latest round date
October 2019
Headquarters
New York, NY
Notable investors
Omega Funds, Aisling Capital, Altitude Life Science Ventures, The Baupost Group, Boxer Capital of the Tavistock Group, EDBI, ECOR1 Capital, Fidelity Management and Research Company
Frequently asked about Nuvation Bio funding
How much has Nuvation Bio raised?
Nuvation Bio has raised $275M in total disclosed funding across the rounds on record.
Who has invested in Nuvation Bio?
Omega Funds, Aisling Capital, Altitude Life Science Ventures, The Baupost Group, Boxer Capital of the Tavistock Group, EDBI are named among the investors backing Nuvation Bio.
What was the latest Nuvation Bio funding round?
The most recent disclosed round is a Series A, announced in October 2019.
Where is Nuvation Bio based?
Nuvation Bio is based in New York, NY.
When did Nuvation Bio last raise?
The last disclosed Nuvation Bio round closed in October 2019 at Series A.
We update the Nuvation Bio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in New York and their backers are listed below.
